About
Avrolifesci is a clinical stage biotechnology company developing topical drug delivery platforms that enable passive and localized or systemic delivery of therapeutic drugs through the skin for conditions including neurology, dermatology, and immunology.
Explore Avrolifesci's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.